nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—Pigmentation disorder—Etoposide—muscle cancer	0.0476	0.0519	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Etoposide—muscle cancer	0.0329	0.0358	CcSEcCtD
Propylthiouracil—Allergic cutaneous angiitis—Methotrexate—muscle cancer	0.0299	0.0326	CcSEcCtD
Propylthiouracil—Neuritis—Vincristine—muscle cancer	0.0263	0.0286	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Doxorubicin—muscle cancer	0.0247	0.0269	CcSEcCtD
Propylthiouracil—DIO1—testis—muscle cancer	0.0245	0.295	CbGeAlD
Propylthiouracil—Interstitial lung disease—Etoposide—muscle cancer	0.0224	0.0245	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Dactinomycin—muscle cancer	0.0206	0.0225	CcSEcCtD
Propylthiouracil—Lung infiltration—Methotrexate—muscle cancer	0.0203	0.0221	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Methotrexate—muscle cancer	0.0197	0.0215	CcSEcCtD
Propylthiouracil—Leukocytoclastic vasculitis—Methotrexate—muscle cancer	0.0194	0.0211	CcSEcCtD
Propylthiouracil—Erythema nodosum—Doxorubicin—muscle cancer	0.019	0.0208	CcSEcCtD
Propylthiouracil—Hepatic failure—Dactinomycin—muscle cancer	0.0177	0.0193	CcSEcCtD
Propylthiouracil—Hepatic failure—Vincristine—muscle cancer	0.0158	0.0173	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Methotrexate—muscle cancer	0.0134	0.0147	CcSEcCtD
Propylthiouracil—TPO—tendon—muscle cancer	0.0133	0.161	CbGeAlD
Propylthiouracil—Skin ulcer—Methotrexate—muscle cancer	0.0122	0.0133	CcSEcCtD
Propylthiouracil—Agranulocytosis—Dactinomycin—muscle cancer	0.0115	0.0125	CcSEcCtD
Propylthiouracil—Neuritis—Doxorubicin—muscle cancer	0.011	0.012	CcSEcCtD
Propylthiouracil—TPO—testis—muscle cancer	0.011	0.133	CbGeAlD
Propylthiouracil—Hepatitis—Dactinomycin—muscle cancer	0.011	0.012	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Vincristine—muscle cancer	0.0107	0.0117	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—muscle cancer	0.0106	0.0115	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—muscle cancer	0.0102	0.0111	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—muscle cancer	0.00979	0.0107	CcSEcCtD
Propylthiouracil—Vasculitis—Methotrexate—muscle cancer	0.00975	0.0106	CcSEcCtD
Propylthiouracil—Alopecia—Dactinomycin—muscle cancer	0.00974	0.0106	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Methotrexate—muscle cancer	0.00893	0.00974	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Etoposide—muscle cancer	0.00871	0.00949	CcSEcCtD
Propylthiouracil—Alopecia—Vincristine—muscle cancer	0.0087	0.00949	CcSEcCtD
Propylthiouracil—Jaundice—Etoposide—muscle cancer	0.00866	0.00944	CcSEcCtD
Propylthiouracil—Leukopenia—Dactinomycin—muscle cancer	0.00859	0.00936	CcSEcCtD
Propylthiouracil—DBH—bone marrow—muscle cancer	0.00841	0.101	CbGeAlD
Propylthiouracil—Agranulocytosis—Etoposide—muscle cancer	0.00829	0.00904	CcSEcCtD
Propylthiouracil—Myalgia—Dactinomycin—muscle cancer	0.00817	0.0089	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Methotrexate—muscle cancer	0.00809	0.00882	CcSEcCtD
Propylthiouracil—Oedema—Dactinomycin—muscle cancer	0.00783	0.00854	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—muscle cancer	0.00773	0.00843	CcSEcCtD
Propylthiouracil—Vertigo—Vincristine—muscle cancer	0.0077	0.0084	CcSEcCtD
Propylthiouracil—Hepatic failure—Methotrexate—muscle cancer	0.00768	0.00838	CcSEcCtD
Propylthiouracil—Leukopenia—Vincristine—muscle cancer	0.00767	0.00836	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Dactinomycin—muscle cancer	0.00766	0.00836	CcSEcCtD
Propylthiouracil—Renal failure acute—Methotrexate—muscle cancer	0.00748	0.00815	CcSEcCtD
Propylthiouracil—DBH—head—muscle cancer	0.00744	0.0898	CbGeAlD
Propylthiouracil—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00732	0.00798	CcSEcCtD
Propylthiouracil—Myalgia—Vincristine—muscle cancer	0.0073	0.00796	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00713	0.00778	CcSEcCtD
Propylthiouracil—Alopecia—Etoposide—muscle cancer	0.00705	0.00768	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Doxorubicin—muscle cancer	0.00701	0.00764	CcSEcCtD
Propylthiouracil—Oedema—Vincristine—muscle cancer	0.00699	0.00763	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Vincristine—muscle cancer	0.00685	0.00747	CcSEcCtD
Propylthiouracil—Dysgeusia—Etoposide—muscle cancer	0.0068	0.00741	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—muscle cancer	0.00665	0.00725	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—muscle cancer	0.00648	0.00706	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00637	0.00695	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00634	0.00691	CcSEcCtD
Propylthiouracil—Paraesthesia—Vincristine—muscle cancer	0.00628	0.00685	CcSEcCtD
Propylthiouracil—Vertigo—Etoposide—muscle cancer	0.00624	0.0068	CcSEcCtD
Propylthiouracil—Leukopenia—Etoposide—muscle cancer	0.00621	0.00678	CcSEcCtD
Propylthiouracil—Body temperature increased—Dactinomycin—muscle cancer	0.00619	0.00675	CcSEcCtD
Propylthiouracil—MPO—renal system—muscle cancer	0.00595	0.0717	CbGeAlD
Propylthiouracil—Thrombocytopenia—Etoposide—muscle cancer	0.00555	0.00605	CcSEcCtD
Propylthiouracil—Body temperature increased—Vincristine—muscle cancer	0.00553	0.00603	CcSEcCtD
Propylthiouracil—Drowsiness—Methotrexate—muscle cancer	0.00532	0.0058	CcSEcCtD
Propylthiouracil—Paraesthesia—Etoposide—muscle cancer	0.00509	0.00555	CcSEcCtD
Propylthiouracil—Somnolence—Etoposide—muscle cancer	0.00504	0.00549	CcSEcCtD
Propylthiouracil—Vomiting—Dactinomycin—muscle cancer	0.00498	0.00543	CcSEcCtD
Propylthiouracil—Agranulocytosis—Methotrexate—muscle cancer	0.00497	0.00541	CcSEcCtD
Propylthiouracil—Rash—Dactinomycin—muscle cancer	0.00494	0.00538	CcSEcCtD
Propylthiouracil—Haemoglobin—Methotrexate—muscle cancer	0.0048	0.00523	CcSEcCtD
Propylthiouracil—Hepatitis—Methotrexate—muscle cancer	0.00478	0.00521	CcSEcCtD
Propylthiouracil—Haemorrhage—Methotrexate—muscle cancer	0.00478	0.00521	CcSEcCtD
Propylthiouracil—Nausea—Dactinomycin—muscle cancer	0.00465	0.00507	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—muscle cancer	0.00461	0.00502	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00452	0.00492	CcSEcCtD
Propylthiouracil—Urticaria—Etoposide—muscle cancer	0.0045	0.00491	CcSEcCtD
Propylthiouracil—MPO—bone marrow—muscle cancer	0.0045	0.0542	CbGeAlD
Propylthiouracil—Jaundice—Doxorubicin—muscle cancer	0.00449	0.0049	CcSEcCtD
Propylthiouracil—Body temperature increased—Etoposide—muscle cancer	0.00448	0.00488	CcSEcCtD
Propylthiouracil—Vomiting—Vincristine—muscle cancer	0.00445	0.00485	CcSEcCtD
Propylthiouracil—Rash—Vincristine—muscle cancer	0.00441	0.00481	CcSEcCtD
Propylthiouracil—Dermatitis—Vincristine—muscle cancer	0.00441	0.0048	CcSEcCtD
Propylthiouracil—Headache—Vincristine—muscle cancer	0.00438	0.00478	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—muscle cancer	0.0043	0.00469	CcSEcCtD
Propylthiouracil—Alopecia—Methotrexate—muscle cancer	0.00422	0.0046	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—muscle cancer	0.00416	0.00453	CcSEcCtD
Propylthiouracil—Nausea—Vincristine—muscle cancer	0.00415	0.00453	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—muscle cancer	0.00414	0.00451	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—muscle cancer	0.00414	0.00451	CcSEcCtD
Propylthiouracil—Dysgeusia—Methotrexate—muscle cancer	0.00407	0.00444	CcSEcCtD
Propylthiouracil—Pruritus—Etoposide—muscle cancer	0.00401	0.00437	CcSEcCtD
Propylthiouracil—MPO—head—muscle cancer	0.00398	0.048	CbGeAlD
Propylthiouracil—MPO—testis—muscle cancer	0.00384	0.0464	CbGeAlD
Propylthiouracil—Vertigo—Methotrexate—muscle cancer	0.00374	0.00407	CcSEcCtD
Propylthiouracil—Leukopenia—Methotrexate—muscle cancer	0.00372	0.00406	CcSEcCtD
Propylthiouracil—Alopecia—Doxorubicin—muscle cancer	0.00365	0.00399	CcSEcCtD
Propylthiouracil—Vomiting—Etoposide—muscle cancer	0.0036	0.00393	CcSEcCtD
Propylthiouracil—Rash—Etoposide—muscle cancer	0.00357	0.0039	CcSEcCtD
Propylthiouracil—Dermatitis—Etoposide—muscle cancer	0.00357	0.00389	CcSEcCtD
Propylthiouracil—Headache—Etoposide—muscle cancer	0.00355	0.00387	CcSEcCtD
Propylthiouracil—Arthralgia—Methotrexate—muscle cancer	0.00354	0.00386	CcSEcCtD
Propylthiouracil—Myalgia—Methotrexate—muscle cancer	0.00354	0.00386	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—muscle cancer	0.00353	0.00384	CcSEcCtD
Propylthiouracil—Nausea—Etoposide—muscle cancer	0.00337	0.00367	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Methotrexate—muscle cancer	0.00332	0.00362	CcSEcCtD
Propylthiouracil—Vertigo—Doxorubicin—muscle cancer	0.00323	0.00353	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—muscle cancer	0.00322	0.00351	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00309	0.00337	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—muscle cancer	0.00307	0.00334	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—muscle cancer	0.00307	0.00334	CcSEcCtD
Propylthiouracil—Paraesthesia—Methotrexate—muscle cancer	0.00305	0.00332	CcSEcCtD
Propylthiouracil—Somnolence—Methotrexate—muscle cancer	0.00302	0.00329	CcSEcCtD
Propylthiouracil—Dyspepsia—Methotrexate—muscle cancer	0.00299	0.00326	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—muscle cancer	0.00294	0.0032	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—muscle cancer	0.00288	0.00314	CcSEcCtD
Propylthiouracil—Urticaria—Methotrexate—muscle cancer	0.0027	0.00294	CcSEcCtD
Propylthiouracil—Body temperature increased—Methotrexate—muscle cancer	0.00268	0.00293	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00268	0.00292	CcSEcCtD
Propylthiouracil—Paraesthesia—Doxorubicin—muscle cancer	0.00264	0.00288	CcSEcCtD
Propylthiouracil—Somnolence—Doxorubicin—muscle cancer	0.00261	0.00285	CcSEcCtD
Propylthiouracil—Dyspepsia—Doxorubicin—muscle cancer	0.00259	0.00282	CcSEcCtD
Propylthiouracil—Pruritus—Methotrexate—muscle cancer	0.0024	0.00262	CcSEcCtD
Propylthiouracil—Urticaria—Doxorubicin—muscle cancer	0.00233	0.00255	CcSEcCtD
Propylthiouracil—Body temperature increased—Doxorubicin—muscle cancer	0.00232	0.00253	CcSEcCtD
Propylthiouracil—Vomiting—Methotrexate—muscle cancer	0.00216	0.00235	CcSEcCtD
Propylthiouracil—Rash—Methotrexate—muscle cancer	0.00214	0.00233	CcSEcCtD
Propylthiouracil—Dermatitis—Methotrexate—muscle cancer	0.00214	0.00233	CcSEcCtD
Propylthiouracil—Headache—Methotrexate—muscle cancer	0.00213	0.00232	CcSEcCtD
Propylthiouracil—Pruritus—Doxorubicin—muscle cancer	0.00208	0.00227	CcSEcCtD
Propylthiouracil—Nausea—Methotrexate—muscle cancer	0.00202	0.0022	CcSEcCtD
Propylthiouracil—Vomiting—Doxorubicin—muscle cancer	0.00187	0.00204	CcSEcCtD
Propylthiouracil—Rash—Doxorubicin—muscle cancer	0.00185	0.00202	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—muscle cancer	0.00185	0.00202	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—muscle cancer	0.00184	0.00201	CcSEcCtD
Propylthiouracil—Nausea—Doxorubicin—muscle cancer	0.00175	0.0019	CcSEcCtD
